Earnings Preview: AbCellera Biologics
Portfolio Pulse from Benzinga Insights
AbCellera Biologics (NASDAQ:ABCL) is set to release its quarterly earnings report on August 3, 2023. Analysts estimate an EPS of $-0.13. The company's past performance shows a pattern of share price changes following earnings reports. The company's shares are currently trading at $7.27, down 39.54% over the last 52-week period.
August 04, 2023 | 11:32 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AbCellera Biologics is expected to report an EPS of $-0.13 in its upcoming earnings report. The company's share price has historically been affected by its earnings reports.
AbCellera Biologics' upcoming earnings report is expected to have a significant impact on its share price, as has been the case with past earnings reports. The estimated EPS of $-0.13, if accurate, could potentially lead to a decrease in share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100